Search research articles
Contact Us
Filters
Showing results (421-430 of 573) with videos related to
Page
of 58
Sort By:
Basic Research in Cardiology
|
November 25, 2016
Identification of cardiovascular risk factors associated with bone marrow cell subsets in patients with STEMI: a biorepository evaluation from the CCTRN TIME and LateTIME clinical trials
Ariadna Contreras, Aaron F Orozco, Micheline Resende, et al.
Circulation. Cardiovascular Quality and Outcomes
|
July 15, 2025
Correction to: 2025 AHA/ACC Clinical Performance and Quality Measures for Patients With Chronic Coronary Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Performance Measures
Marlene S Williams, Glenn N Levine, Dinesh Kalra, et al.
Circulation
|
March 19, 2003
The VIVA trial: Vascular endothelial growth factor in Ischemia for Vascular Angiogenesis
Timothy D Henry, Brian H Annex, George R McKendall, et al.
American Heart Journal
|
December 6, 2011
Developing mechanistic insights into cardiovascular cell therapy: Cardiovascular Cell Therapy Research Network Biorepository Core Laboratory rationale
Claudia Zierold, Marjorie A Carlson, Udo C Obodo, et al.
Scientific Reports
|
July 2, 2017
Circulating Biomarkers to Identify Responders in Cardiac Cell therapy
Jesse V Jokerst, Nicholas Cauwenberghs, Tatiana Kuznetsova, et al.
JACC. Cardiovascular Interventions
|
July 4, 2016
The Impact of Timing of Ischemic and Hemorrhagic Events on Mortality After Percutaneous Coronary Intervention: The ADAPT-DES Study
Sorin J Brener, Ajay J Kirtane, Thomas D Stuckey, et al.
Journal of the American Heart Association
|
January 21, 2020
Prehospital Activation of Hospital Resources (PreAct) ST-Segment-Elevation Myocardial Infarction (STEMI): A Standardized Approach to Prehospital Activation and Direct to the Catheterization Laboratory for STEMI Recommendations From the American Heart Association's Mission: Lifeline Program
Michael C Kontos, Michael R Gunderson, Jessica K Zegre-Hemsey, et al.
European Heart Journal
|
January 10, 2018
Autologous CD34+ cell therapy improves exercise capacity, angina frequency and reduces mortality in no-option refractory angina: a patient-level pooled analysis of randomized double-blinded trials
Timothy D Henry, Douglas W Losordo, Jay H Traverse, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
October 8, 2020
Coronary Vascular Function and Cardiomyocyte Injury: A Report From the WISE-CVD
Ahmed AlBadri, Janet Wei, Odayme Quesada, et al.
Circulation. Cardiovascular Quality and Outcomes
|
April 30, 2025
2025 AHA/ACC Clinical Performance and Quality Measures for Patients With Chronic Coronary Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Performance Measures
Marlene S Williams, Glenn N Levine, Dinesh Kalra, et al.
Page
of 58
Search research articles
Search
Showing results (421-430 of 573) with videos related to
Sort By:
Page
of 58
Basic Research in Cardiology
|
November 25, 2016
Identification of cardiovascular risk factors associated with bone marrow cell subsets in patients with STEMI: a biorepository evaluation from the CCTRN TIME and LateTIME clinical trials
Ariadna Contreras, Aaron F Orozco, Micheline Resende, et al.
Circulation. Cardiovascular Quality and Outcomes
|
July 15, 2025
Correction to: 2025 AHA/ACC Clinical Performance and Quality Measures for Patients With Chronic Coronary Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Performance Measures
Marlene S Williams, Glenn N Levine, Dinesh Kalra, et al.
Circulation
|
March 19, 2003
The VIVA trial: Vascular endothelial growth factor in Ischemia for Vascular Angiogenesis
Timothy D Henry, Brian H Annex, George R McKendall, et al.
American Heart Journal
|
December 6, 2011
Developing mechanistic insights into cardiovascular cell therapy: Cardiovascular Cell Therapy Research Network Biorepository Core Laboratory rationale
Claudia Zierold, Marjorie A Carlson, Udo C Obodo, et al.
Scientific Reports
|
July 2, 2017
Circulating Biomarkers to Identify Responders in Cardiac Cell therapy
Jesse V Jokerst, Nicholas Cauwenberghs, Tatiana Kuznetsova, et al.
JACC. Cardiovascular Interventions
|
July 4, 2016
The Impact of Timing of Ischemic and Hemorrhagic Events on Mortality After Percutaneous Coronary Intervention: The ADAPT-DES Study
Sorin J Brener, Ajay J Kirtane, Thomas D Stuckey, et al.
Journal of the American Heart Association
|
January 21, 2020
Prehospital Activation of Hospital Resources (PreAct) ST-Segment-Elevation Myocardial Infarction (STEMI): A Standardized Approach to Prehospital Activation and Direct to the Catheterization Laboratory for STEMI Recommendations From the American Heart Association's Mission: Lifeline Program
Michael C Kontos, Michael R Gunderson, Jessica K Zegre-Hemsey, et al.
European Heart Journal
|
January 10, 2018
Autologous CD34+ cell therapy improves exercise capacity, angina frequency and reduces mortality in no-option refractory angina: a patient-level pooled analysis of randomized double-blinded trials
Timothy D Henry, Douglas W Losordo, Jay H Traverse, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
October 8, 2020
Coronary Vascular Function and Cardiomyocyte Injury: A Report From the WISE-CVD
Ahmed AlBadri, Janet Wei, Odayme Quesada, et al.
Circulation. Cardiovascular Quality and Outcomes
|
April 30, 2025
2025 AHA/ACC Clinical Performance and Quality Measures for Patients With Chronic Coronary Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Performance Measures
Marlene S Williams, Glenn N Levine, Dinesh Kalra, et al.
Page
of 58